Marinesco-Sjögren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS

Nature Neuroscience

Volumn 18, Issue 2, 2015, Pages 227-238

  Filézac De L'Etang, Audrey ^a   Maharjan, Niran ^a   Cordeiro Branã, Marisa ^a   Ruegsegger, Céline ^a   Rehmann, Ruth ^a   Goswami, Anand ^b   Roos, Andreas ^b,e   Troost, Dirk ^c   Schneider, Bernard L ^d   Weis, Joachim ^b   Saxena, Smita ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d EPFL   (Switzerland)

^e LEIBNIZ INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN ISAS E V   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 6; ALPHA NERVE FIBER; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CEREBELLAR ATAXIA; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HOMEOSTASIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MARINESCO SJOGREN SYNDROME; MOTONEURON; MOUSE; MUSCLE DENERVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN QUALITY; SPINAL CORD; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPINOCEREBELLAR DEGENERATION; TRANSGENIC MOUSE;

GUANINE NUCLEOTIDE EXCHANGE FACTOR; SIL1 PROTEIN, MOUSE; SOD1 G93A PROTEIN; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; SPINOCEREBELLAR DEGENERATIONS; SUPEROXIDE DISMUTASE;

EID: 84923189622     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3903     Document Type: Article

References (60)

1. Saxena, S. & Caroni, P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71, 35-48 (2011).
2. Cleveland, D.W. & Rothstein, J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2, 806-819 (2001).
3. Boilleé, S., Vande Velde, C. & Cleveland, D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52, 39-59 (2006).
4. Kanning, K.C., Kaplan, A. & Henderson, C.E. Motor neuron diversity in development and disease. Annu. Rev. Neurosci. 33, 409-440 (2010).
5. Frey, D. et al. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 20, 2534-2542 (2000).
6. Pun, S., Santos, A.F., Saxena, S., Xu, L. & Caroni, P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 9, 408-419 (2006).
7. Hegedus, J., Putman, C.T., Tyreman, N. & Gordon, T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Physiol. (Lond.) 586, 3337-3351 (2008).
8. Saxena, S., Cabuy, E. & Caroni, P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 12, 627-636 (2009).
9. Lee, J. & Ozcan, U. Unfolded protein response signaling and metabolic diseases. J. Biol. Chem. 289, 1203-1211 (2014).
10. Wang, S. & Kaufman, R.J. How does protein misfolding in the endoplasmic reticulum affect lipid metabolism in the liver? Curr. Opin. Lipidol. 25, 125-132 (2014).
11. Doyle, K.M. et al. Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J. Cell. Mol. Med. 15, 2025-2039 (2011).
12. Hetz, C. & Mollereau, B. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci. 15, 233-249 (2014).
13. Walter, P. & Ron, D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334, 1081-1086 (2011).
14. Wang, S. & Kaufman, R.J. The impact of the unfolded protein response on human disease. J. Cell Biol. 197, 857-867 (2012).
15. Kimata, Y. & Kohno, K. Endoplasmic reticulum stress-sensing mechanisms in yeast and mammalian cells. Curr. Opin. Cell Biol. 23, 135-142 (2011).
16. Hetz, C., Martinon, F., Rodriguez, D. & Glimcher, L.H. The unfolded protein response: integrating stress signals through the stress sensor IRE1alpha. Physiol. Rev. 91, 1219-1243 (2011).
17. Saxena, S. et al. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron 80, 80-96 (2013).
18. Kaplan, A. et al. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron 81, 333-348 (2014).
19. Zhao, L., Longo-Guess, C., Harris, B.S., Lee, J.W. & Ackerman, S.L. Protein accumulation and neurodegeneration in the woozy mutant mouse is caused by disruption of SIL1, a cochaperone of BiP. Nat. Genet. 37, 974-979 (2005).
20. Chung, K.T., Shen, Y. & Hendershot, L.M. BAP, a mammalian BiP-associated protein, is a nucleotide exchange factor that regulates the ATPase activity of BiP. J. Biol. Chem. 277, 47557-47563 (2002).
21. Anttonen, A.K. et al. The gene disrupted in Marinesco-Sjögren syndrome encodes SIL1, an HSPA5 cochaperone. Nat. Genet. 37, 1309-1311 (2005).
22. Senderek, J. et al. Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy. Nat. Genet. 37, 1312-1314 (2005).
23. Roos, A. et al. Myopathy in Marinesco-Sjogren syndrome links endoplasmic reticulum chaperone dysfunction to nuclear envelope pathology. Acta Neuropathol. 127, 761-777 (2014).
24. Krieger, M. et al. SIL1 mutations and clinical spectrum in patients with Marinesco-Sjogren syndrome. Brain 136, 3634-3644 (2013).
25. Gorbatyuk, M.S. et al. Glucose regulated protein 78 diminishes alpha-synuclein neurotoxicity in a rat model of Parkinson disease. Mol. Ther. 20, 1327-1337 (2012).
26. Yan, M., Li, J. & Sha, B. Structural analysis of the Sil1-Bip complex reveals the mechanism for Sil1 to function as a nucleotide-exchange factor. Biochem. J. 438, 447-455 (2011).
27. Nishitoh, H. et al. ALS-linked mutant SOD1 induces ER stress-and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 22, 1451-1464 (2008).
28. Bernard-Marissal, N. et al. Reduced calreticulin levels link endoplasmic reticulum stress and Fas-triggered cell death in motor neurons vulnerable to ALS. J. Neurosci. 32, 4901-4912 (2012).
29. Homma, K. et al. SOD1 as a molecular switch for initiating the homeostatic ER stress response under zinc deficiency. Mol. Cell 52, 75-86 (2013).
30. Walker, A.K. et al. ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation. PLoS ONE 8, e81170 (2013).
31. Atkin, J.D. et al. Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol. Dis. 30, 400-407 (2008).
32. Vucic, S. & Kiernan, M.C. Upregulation of persistent sodium conductances in familial ALS. J. Neurol. Neurosurg. Psychiatry 81, 222-227 (2010).
33. Turner, M.R. et al. Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS. J. Neurol. Neurosurg. Psychiatry 76, 1279-1285 (2005).
34. Wegorzewska, I., Bell, S., Cairns, N.J., Miller, T.M. & Baloh, R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA 106, 18809-18814 (2009).
35. Ma, H., Groth, R.D., Wheeler, D.G., Barrett, C.F. & Tsien, R.W. Excitation-transcription coupling in sympathetic neurons and the molecular mechanism of its initiation. Neurosci. Res. 70, 2-8 (2011).
36. Slemmer, J.E., De Zeeuw, C.I. & Weber, J.T. Don't get too excited: mechanisms of glutamate-mediated Purkinje cell death. Prog. Brain Res. 148, 367-390 (2005).
37. Kitao, Y. et al. ORP150/HSP12A regulates Purkinje cell survival: a role for endoplasmic reticulum stress in cerebellar development. J. Neurosci. 24, 1486-1496 (2004).
38. Prahlad, V. & Morimoto, R.I. Integrating the stress response: lessons for neurodegenerative diseases from C. elegans. Trends Cell Biol. 19, 52-61 (2009).
39. Wang, J. et al. An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet. 5, e1000350 (2009).
40. Kikuchi, H. et al. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc. Natl. Acad. Sci. USA 103, 6025-6030 (2006).
41. Prause, J. et al. Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 1581-1600 (2013).
42. Farg, M.A. et al. Mutant FUS induces endoplasmic reticulum stress in amyotrophic lateral sclerosis and interacts with protein disulfide-isomerase. Neurobiol. Aging 33, 2855-2868 (2012).
43. Ilieva, E.V. et al. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 130, 3111-3123 (2007).
44. Uehara, T. et al. S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441, 513-517 (2006).
45. Shatunov, A. et al. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol. 9, 986-994 (2010).
46. Watts, G.D. et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377-381 (2004).
47. Johnson, J.O. et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68, 857-864 (2010).
48. Senderek, J. et al. Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am. J. Hum. Genet. 84, 511-518 (2009).
49. Johnson, J.O. et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 17, 664-666 (2014).
50. Zimmer, C., Gosztonyi, G., Cervos-Navarro, J., von Moers, A. & Schroder, J.M. Neuropathy with lysosomal changes in Marinesco-Sjögren syndrome: fine structural findings in skeletal muscle and conjunctiva. Neuropediatrics 23, 329-335 (1992).
51. Schaeren-Wiemers, N. & Gerfin-Moser, A. A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry 100, 431-440 (1993).
52. Mueller, M. et al. Macrophage response to peripheral nerve injury: the quantitative contribution of resident and hematogenous macrophages. Lab. Invest. 83, 175-185 (2003).
53. Rishal, I., Rozenbaum, M. & Fainzilber, M. Axoplasm isolation from rat sciatic nerve. J. Vis. Exp. 2010, e2087 (2010).
54. Gunasekera, K., Wuthrich, D., Braga-Lagache, S., Heller, M. & Ochsenreiter, T. Proteome remodelling during development from blood to insect-form Trypanosoma brucei quantified by SILAC and mass spectrometry. BMC Genomics 13, 556 (2012).
55. Al Kaabi, A., Traupe, T., Stutz, M., Buchs, N. & Heller, M. Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy. PLoS ONE 7, e46822 (2012).
56. Dirren, E. et al. Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord. Hum. Gene Ther. 25, 109-120 (2014).
57. Stevens, J.C. et al. Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag-implications for research into amyotrophic lateral sclerosis (ALS). PLoS ONE 5, e9541 (2010).
58. Shen, J., Chen, X., Hendershot, L. & Prywes, R. ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev. Cell 3, 99-111 (2002).
59. Gros-Louis, F., Soucy, G., Lariviere, R. & Julien, J.P. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J. Neurochem. 113, 1188-1199 (2010).
60. Park, K.H.J., Franciosi, S. & Leavitt, B.R. Postnatal muscle modification by myogenic factors modulates neuropathology and survival in an ALS mouse model. Nat. Commun. 4, 2906 (2013).